Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
When redeeming rewards, several factors can influence your choices. Learn what to consider to ensure you get the best value for your points.
17,088 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Chipotle faces its first full year of negative comps while McDonald’s leads with traffic recovery and value pricing. ...
A once-overlooked dividend ETF is delivering double-digit gains this year, signaling a shift from megacap leadership ...
A major bank CEO is signaling a bold shift: AI spending could reach trillions. This article explains what that means ...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
Walmart isn't biggest company anymore, but its growth story isn t over. A new catalyst—driving e commerce, membership...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
Two restaurant names dominate growth discussions: Chipotle and Sweetgreen. This guide breaks down which stock could o...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
Costco's strength goes beyond its membership fees. This article reveals how Kirkland Signature quietly grew into Cost...
Momentum can flip quickly in growth stocks, but today some names look cheap for the upside potential. This guide high...